SCHEDULE 13D/A: Boxer Capital Entities Restructure Holdings in Tango Therapeutics, Aaron Davis Maintains 10% Stake
Schedule 13D Amendment
An amendment to Schedule 13D reveals a restructuring of beneficial ownership in Tango Therapeutics, Inc., with BCTG Holdings, LLC distributing its shares to MVA Investors, LLC and Boxer Capital Management, LLC, while Aaron I. Davis's aggregate beneficial ownership remains at approximately 10%.
Summary
- BCTG Holdings, LLC distributed 6,770,357 shares of Tango Therapeutics Common Stock to an account managed by Boxer Capital Management, LLC on December 30, 2024.
- BCTG Holdings, LLC also distributed 218,093 shares of Tango Therapeutics Common Stock to MVA Investors, LLC on December 30, 2024.
- These distributions were made for no consideration.
- As a result of these distributions, BCTG Holdings, LLC has ceased to beneficially own any shares of Common Stock of the Issuer, falling below the 5% reporting threshold.
- Aaron I. Davis, along with the other Reporting Persons (MVA Investors, LLC and Boxer Capital Management, LLC), collectively beneficially own 10,740,385 shares, representing 9.996% of the outstanding Common Stock.
- Boxer Capital Management, LLC now beneficially owns 10,380,999 shares, representing 9.7% of the class.
- MVA Investors, LLC now beneficially owns 326,886 shares, representing 0.3% of the class.
- The total outstanding shares used for percentage calculation is 107,450,318, which includes 107,417,818 shares outstanding as of November 1, 2024, plus 32,500 shares subject to options held by Mr. Davis exercisable within 60 days.
Sentiment
Score: 5
Explanation: The document is neutral as it reports a factual restructuring of beneficial ownership among related entities, with no direct positive or negative implications for the company's operational or financial performance.
Future Outlook
NA
Industry Context
This filing primarily details a restructuring of beneficial ownership among related investment entities and does not provide broader industry trends or competitive analysis. It reflects internal portfolio management decisions by the reporting persons rather than a market-driven event.
Related Party Transactions
- BCTG Holdings, LLC distributed 6,770,357 shares to an account managed by Boxer Capital Management, LLC and 218,093 shares to MVA Investors, LLC for no consideration. All these entities are part of the same reporting group, managed or controlled by Aaron I. Davis.
Stakeholder Impact
- Shareholders: The restructuring of beneficial ownership among the reporting persons clarifies the holdings of individual entities within the group, but the aggregate beneficial ownership by Aaron I. Davis and his associated entities remains substantial at approximately 10%. This indicates continued significant investor interest and influence from this group.
Key Dates
| Date | Description |
|---|---|
| 2021-08-20 | Original Schedule 13D filing date by BCTG Holdings, MVA Investors, Mr. Davis and certain other persons. |
| 2022-01-04 | Amendment No. 1 filing date. |
| 2023-08-16 | Amendment No. 2 filing date. |
| 2023-10-18 | Amendment No. 3 filing date. |
| 2024-10-15 | Amendment No. 4 filing date. |
| 2024-10-28 | Amendment No. 5 filing date. |
| 2024-11-01 | Date as of which 107,417,818 shares of Common Stock were outstanding, as reported in the Issuer's 10-Q. |
| 2024-11-06 | Date Issuer's 10-Q was filed with the Securities and Exchange Commission. |
| 2024-11-07 | Amendment No. 6 filing date. |
| 2024-12-30 | Date of event requiring this filing; BCTG Holdings, LLC distributed shares and ceased to beneficially own more than 5% of the outstanding shares. |
| 2025-01-02 | Signature date for the current Schedule 13D Amendment No. 7. |
Keywords
Tango Therapeutics, SEC filing, Schedule 13D, beneficial ownership, Boxer Capital Management, MVA Investors, Aaron I. Davis, share distribution, corporate governance, investment management
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.